REQUEST A DEMO
Total
USD $0.00
« Back to previous page

China Pharmaceutical Sector Report 2019 4th Quarter

An EMIS Insights Industry Report
EMIS is an ISI Emerging Markets Group Company
Date: January 2020
Pages: 62
Available in: English

In the third quarter of 2019, China’s pharmaceutical production volume declined by 47% y/y to 304,000 tonnes, while the sales of pharmaceuticals dropped by 44.2% y/y to 322,700 tonnes. The centralised drug procurement scheme which had been launched in China at the end of 2018, resulted in a notable decline in drug prices. Many producers experienced significant drop in profits and some even suffered financial losses, that made production economically senseless, and finally resulted in drug shortages. Furthermore, there was a high pressure to limit the output of some heavily polluting API plants due to environmental concerns, which also had a negative effect on drug production. During this period, the revenue of China’s pharmaceutical sector totalled RMB 595.7bn, representing
an 8% y/y increase, while its total profit amounted to RMB 78.2bn, up by 11.1% y/y.

 

This report provides a complete and detailed analysis of the pharmaceutical sector for China. EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

  • Understand the key elements at play in the pharmaceutical sector in China
  • Access forecasts for growth in the sector
  • View key data on production and sales for the sector in China
  • Crystallise the forces both driving and restraining this sector in China
  • Build a complete perspective on sector trade, investment and employment
  • Understand the competitive landscape and who the major players are
  • View M&A activity and major deals
  • Gain an understanding of the regulatory environment for the sector in China
  • Build a clear picture of trends and issues for sub-sectors (western medicine, traditional Chinese medicine)

See below for a complete table of report contents:

China Pharmaceutical Sector Report 2019 4th Quarter - Page 1
Buy full report USD 495.00 Payment methods include:

DOWNLOAD A SAMPLE
Have a question?

Email us at: customerenquiries@emis.com

SEE BELOW FOR A COMPLETE TABLE OF REPORT CONTENTS:

China Pharmaceutical Sector Report 2019 4th Quarter -  Page 3
China Pharmaceutical Sector Report 2019 4th Quarter -  Page 4
China Pharmaceutical Sector Report 2019 4th Quarter -  Page 13
China Pharmaceutical Sector Report 2019 4th Quarter -  Page 19
ONCE YOU HAVE COMPLETED YOUR PURCHASE,
YOU WILL BE ABLE TO DOWNLOAD THIS REPORT IMMEDIATELY AS A PDF
If you have any questions, please contact customerenquires@emis.com
Buy full report
Need ongoing access to company, industry or country information?